Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality I...(ve demonstrated howit can drive improvem...),Health
Navigation Links
Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives
Date:9/14/2007
ve demonstrated how it can drive improvements in clinical performance," said Sam Nussbaum, MD, executive vice president and chief medical officer, WellPoint, Inc. "With a common goal of improving quality, we are continuing to engage hospitals and physicians in patient safety programs, raising the bar for the quality of care."
To view a webcast of today's forum at the National Press Club in Washington, D.C., please visit http://www.bcbs.com/news/bluetvradio/improving-healthcare-quality/.
The Blue Cross and Blue Shield Association is a national federation of 39 independent, community-based and locally operated Blue Cross and Blue Shield companies that collectively provide healthcare coverage for more than 99 million individuals - nearly one-in-three of all Americans. For more information on the Blue Cross and Blue Shield Association and its member companies, please visit http://www.BCBS.com.
CONTACT: Lisa Johnson of Blue Cross and Blue Shield Association,
+1-312-297-6358, lisa.johnson@bcbsa.com
Additional Media Contacts:
Blue Cross and Blue Shield of Alabama
Larry Estock
205.220.2524
Duke University Health System
Doug Stokke
919.660.1304
Premier Inc.
Alven Weil
704.733.5797
WellPoint, Inc.
Jim Gavin
317.488.6426
'/>"/>
| SOURCE Blue Cross and Blue Shield Association Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. Memory problem? solve a crossword
2. FDA attacks American Red Cross for blood violations
3. Encephalitis Death Toll In U.P. Crosses 200 Mark.
4. Encephalitis Deaths Cross 220 in Uttar Pradesh
5. Flu-Drugs Are Causing Resistance Across The World
6. Condom Vending Machines To Be Installed Across Indian States
7. First Crossover Kidney Transplantation In Germany
8. Bird Flu Infection Of Chinese Girl Prompts Fear Of Spread Across Asia
9. Chicken pox Spreads Across Firozabad
10. The Cleveland Clinic Expands Its Services across the World via the Net
11. Blue Cross Signs Up 110,000 Minnesotans For Part D Medicare Plans
Post Your Comments:
(Date:5/12/2008)... Allied Healthcare Products,Inc. (Nasdaq: AHPI )...quarter ending March 31 fell 64 percent, from abou...ut $100,000 in the current quarter, or 1 cent per,...about $240,000 compared to the,third quarter of th...osts,this fiscal year eroded margins and profits f...
(Date:5/12/2008)...rt, of System, WASHINGTON, May 12 /PRNewswire-U...VA), the nation,s largest single employer of nurse...its top professionals., "VA nurses are the comp...stem," stated Secretary of Veterans Affairs Dr. Ja...s from the personal, one-on-one interaction,betwee...
(Date:5/12/2008)...Montreal, May 12, 2008 A team of researchers has ...il protects the heart in mice with Duchenne muscul...Des Rosiers from the Universit de Montral and the .... Basil Petrof of the Research Institute of the Mc...tian Deschepper of the Institut de recherches clin...
(Date:5/12/2008)...or the 12 weeks ended March ...ewswire-FirstCall/ -- Matrixx,Initiatives, Inc. (N...pany,that develops and markets products that provi...today announced its financial results for the four... For the fourth quarter ended March 31, 2008, the ...
Breaking Medicine News(10 mins):Health News:Allied Healthcare Net Falls on Manufacturing Delays 2Health News:Allied Healthcare Net Falls on Manufacturing Delays 3Health News:Allied Healthcare Net Falls on Manufacturing Delays 4Health News:Allied Healthcare Net Falls on Manufacturing Delays 5Health News:New approach to protect the hearts of patients with muscular dystrophy 2Health News:New approach to protect the hearts of patients with muscular dystrophy 3Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 2Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 3Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 4Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 5Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 6Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 7Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 8[0] Allied Healthcare Net Falls on Manufacturing Delays[0] VA Honors Top Nurses[0] New approach to protect the hearts of patients with muscular dystrophy[0] Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year
...y of Texas has found that caffeine is often used t.... Sleep apnea is a condition characterized by cess...re infants. However, there is a growing concern ov...culatory system.// Researchers in Texas analyzed t...
...vels of the amino acid homocysteine may increase t... researchers report. It is still too soon to be ce...e the risk of Alzheimer's// and other types of dem...stigating. Prior research has shown that elevated ...
... York, there has been a declining trend in mortali... has increased. Researchers at the University of T...e deadliest form of skin cancer, between 1981 and ...ncrease in cases among men - from 2.0 cases per 15...
...y of Texas, offer some valuable advice on how to m... is essential for healthy bones and teeth, and hel...se. Doctors believe that natural sunlight helps th...of natural sunlight three times a week should be a...
Other Medicine News:Health News:Caffeine reduces infant blood flow 2Health News:High Levels of Protein Linked to Brain Shrinkage 2(Date:5/9/2008)...swire/ -- Osteoarthritis is a,painful and potentia...million people in the United States. It is caused ...novel investigational pain medication,tapentadol, ...icant relief,for patients with joint-disease pain,...fewer gastrointestinal side effects than those tre...
(Date:5/9/2008)...all/ -- Ardea Biosciences, Inc.,(Nasdaq: RDEA ), ... of,small- molecule therapeutics for the treatment...ng gout, today announced that John W. Beck,has bee...rations and Chief,Financial Officer effective May ...rs shortly thereafter. The Company also reported r...
(Date:5/8/2008)...all/ -- DATATRAK International, Inc.,(Nasdaq: DAT...global,eClinical solutions for the clinical trials...r the first quarter of 2008., For the three month...ately 41% to $2,088,000 and the Company reported a... both a basic and diluted basis. These,results com...
(Date:5/8/2008)...ial of asenapine in the treatment of ...TON, May 8 /- Schering-Plou...an overview of asenapine clinical trials,from the ...Meeting of the,American Psychiatric Association in... involving patients with bipolar I disorder and sc...
Breaking Medicine Technology:Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7TFAH Applauds Release of CDCs State Specific Public Health Emergency Preparedness Report 12366 1TFAH Applauds Release of CDCs State Specific Public Health Emergency Preparedness Report 12366 2Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases 3427 1Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases 3427 2Cognitive Impairment Declining in Older Adults 12363 1Cognitive Impairment Declining in Older Adults 12363 2Drinking milk may help ease the pressure 2277 1Drinking milk may help ease the pressure 2277 2[0] Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile[0] Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results[0] DATATRAK International Reports First Quarter Results for 2008[0] Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting
...NESS WIRE)--Apr 12, 2007 - AVEO,Pharmaceuticals, I...scovery and development of novel, targeted cancer ...total of 12 oral and poster,presentations at the A...ual Meeting on April 14-18, 2007, in Los Angeles,...e cancer community the,pioneering oncology researc...
...--The costs of eradicating,poliomyelitis from the ...ort term, are much lower than the long term costs ...n. And a recently developed,monovalent vaccine is ...oliomyelitis than an existing trivalent vaccine. T...line and in an upcoming,issue of The Lancet. , Bot...
Other Medicine Technology:AVEO Pharmaceuticals Novel Oncology Research Platform and Clinical,Pipeline to Be Featured at AACR 2AVEO Pharmaceuticals Novel Oncology Research Platform and Clinical,Pipeline to Be Featured at AACR 3Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3Level 1 enables hospitals to standardize all multiparameter patient monitors to a single temperature monitoring series. Our temperature monitoring disposale probes and reusable cables are superior in
Level 1 enables hospitals to standardize all multiparameter patient monitors to a single temperature monitoring series. Our temperature monitoring disposale probes and reusable cables are superior in
...tbeat. The bodys warmth beneath drapes. The life-g...ns are yours to guard, measure, stabilize and cros...roducts helps you do your job, giving you the info... precise management of your patients stability dur...
...aser system used in neurophysiology for studying e...just the amplitude and/or the duration of the stim...laser emission in an ongoing manner by acting on t...r include the high repeatability of the impulses, ...
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |